Stefan Heller - Jun 10, 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Tighe Reardon, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
3
Date filed
6/10/2021, 07:10 PM
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JANX Common Stock 96.1K Jun 10, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.